Methohexital

In the US, Methohexital (methohexital systemic) is a member of the drug class general anesthetics and is used to treat Anesthesia and Anesthetic Adjunct.

US matches:

• Methohexital

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01AF01,N05CA15

CAS registry number (Chemical Abstracts Service)

0000151-83-7

Chemical Formula

C14-H18-N2-O3

Molecular Weight

262

Therapeutic Category

Anesthetic, injectable

Chemical Name

2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-

Foreign Names

• Methohexitalum (Latin)
• Methohexital (German)
• Méthohexital (French)
• Metohexital (Spanish)

Generic Names

• Methohexital (OS: BAN)
• Méthohexital (OS: DCF)
• Enallynymalum (IS)
• Methohexitone (IS)
• Metoesital (IS)
• Methohexital (PH: USP 32)
• Methohexital Sodium (OS: BANM)
• Methohexitone Sodium (IS)
• Methohexital Sodium (PH: USP 32)
• Methohexitone Injection (PH: BP 1999)

Brand Names

• Brevital
  JHP, United States; King, United States; Lilly, Kenya; Lilly, Nigeria; Lilly, Tanzania; Lilly, Uganda



• Brietal Sodium
  Lilly, Israel; Lilly, Kenya; Lilly, Nigeria; Lilly, Tanzania; Lilly, Uganda



• Brietal
  Hikma, Austria; Lilly, Russian Federation

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.